Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

dolasetron mesylate

DRUG

granisetron hydrochloride

DRUG

ondansetron

DRUG

prochlorperazine

PROCEDURE

quality-of-life assessment

Trial Locations (15)

11030

CCOP - North Shore University Hospital, Manhasset

29615

CCOP - Greenville, Greenville

36688

MBCCOP - Gulf Coast, Mobile

43206

CCOP - Columbus, Columbus

45429

CCOP - Dayton, Dayton

62526

CCOP - Central Illinois, Decatur

80224

CCOP - Colorado Cancer Research Program, Incorporated, Denver

96813

MBCCOP - Hawaii, Honolulu

85006-2726

CCOP - Western Regional, Arizona, Phoenix

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

67214-3882

CCOP - Wichita, Wichita

49007-3731

CCOP - Kalamazoo, Kalamazoo

07601

CCOP - Northern New Jersey, Hackensack

27104-4241

CCOP - Southeast Cancer Control Consortium, Winston-Salem

98405-0986

CCOP - Northwest, Tacoma

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gary Morrow

OTHER

NCT00020657 - Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Biotech Hunter | Biotech Hunter